Common Stock, Shares, Outstanding of Estrella Immunopharma, Inc. from 31 Jan 2021 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Estrella Immunopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Jan 2021 to 30 Sep 2025.
  • Estrella Immunopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 37,765,589.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Estrella Immunopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 37,765,589 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 37,065,589 +454,719 +1.2% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 36,165,589 -370,391 -1% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 36,193,891 +992,659 +2.8% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 36,610,870 +35,632,627 +3643% 30 Jun 2024 10-K 27 Sep 2024 2024 FY
Q1 2024 36,535,980 +35,116,280 +2474% 31 Mar 2024 10-Q 15 May 2024 2024 Q3
Q4 2023 35,201,232 +33,781,532 +2379% 31 Dec 2023 10-Q 14 Feb 2024 2023 Q2
Q3 2023 35,201,232 +33,781,532 +2379% 30 Sep 2023 10-Q 20 Nov 2023 2024 Q1
Q2 2023 978,243 -441,457 -31% 30 Jun 2023 10-Q 14 Nov 2024 2025 Q1
Q1 2023 1,419,700 0 0% 31 Mar 2023 10-Q 18 May 2023
Q4 2022 1,419,700 0 0% 31 Dec 2022 10-Q 01 Aug 2023 2023 Q2
Q3 2022 1,419,700 0 0% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 1,419,700 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 1,419,700 0 0% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 1,419,700 0 0% 31 Dec 2021 10-K 14 Mar 2023 2022 FY
Q3 2021 1,419,700 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q1 2021 1,419,700 31 Mar 2021 10-Q 16 May 2022 2022 Q1
Q4 2020 1,419,700 31 Jan 2021 10-Q 16 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.